Status:
UNKNOWN
Can Gluten-free Diet Prevent the Destruction of Beta-cells During Remission?
Lead Sponsor:
Herlev Hospital
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
2-18 years
Phase:
EARLY_PHASE1
Brief Summary
Type 1 diabetes (T1D) emerge when the auto-immune destruction exceeds the beta cell's regenerative capacity. The patients' beta-cell capacity increases shortly after onset when glucotoxicity decreases...
Detailed Description
Introduction Type 1 diabetes (T1D) is characterised by a progressive loss and destruction of beta cells. The optimal timing of intervention is during remission when the beta cells regenerative power i...
Eligibility Criteria
Inclusion
- Newly diagnosed with type 1 diabetes (duration \< 3 month)
Exclusion
- Diabetes duration \> 3 months,
- not type 1 diabetes
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02284815
Start Date
March 1 2012
End Date
August 1 2015
Last Update
November 6 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.